• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Faster Drug Discovery: Yseop & AWS Unveils GenAI Tool for Biopharma R&D

by Syed Hamza Sohail 05/02/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

·      Yseop, a world-leading Artificial Intelligence (AI) software company and pioneer in Generative AI, has announced today the development of an enhanced Generative AI application tailored for the Biopharma industry, with support from Amazon Web Services (AWS).

·      A member of the AWS Partner Network (APN), Yseop has strategically utilized AWS since its inception, leveraging its robust security and scalability to enhance its Large Language Model (LLM) ecosystem, infrastructure, and technological expertise. With AWS’s backing, Yseop aims to empower leading Biopharma companies globally, facilitating the expedited delivery of pharmaceuticals and vaccines to market.

Yseop and AWS Revolutionize Biopharma with Enhanced Generative AI Application

By harnessing the capabilities of AWS, Yseop now seamlessly embeds LLM models, facilitating the generation of comprehensive scientific content while ensuring compliance with the stringent security standards of the pharmaceutical sector. This collaborative effort between AWS and Yseop enables scientific and medical writers within prominent pharmaceutical corporations to significantly augment their productivity, thereby accelerating the dissemination of therapeutics to those in need.

Miguel Alava, AWS Managing Director, Software Companies EMEA, emphasized the joint initiative between Yseop and AWS, stating, “Yseop and AWS are collaborating to democratize access to generative AI, delivering unparalleled business value to the life sciences sector while navigating challenges such as scalability and trust. Leveraging capabilities like Amazon SageMaker and Amazon Bedrock, Yseop can effectively address the rigorous AI software and data requirements prevalent across Biopharma.”

In the Biopharma domain, Yseop’s collaboration with AWS offers a multitude of advantages, including accelerating time-to-value through a pre-configured SaaS enterprise platform powered by AWS, securely scaling content generation across organizations via AWS managed services and tools such as Amazon EKS, Amazon RDS, and Infrastructure as Code CDK, managing end-to-end data and document flows with enhanced security features, and harnessing the latest AI capabilities through a model-agnostic SaaS powered by AWS SageMaker, AWS Inferentia, and AWS EC2.

Crucially, AWS provides Yseop and its clientele with a fully managed, private cloud environment, crucial for compliance within the regulated life science industry.

Yseop stands at the forefront of Generative AI for life science and pharmaceutical enterprises, revolutionizing content automation solutions with a human-centric, AI platform. Serving as a trailblazer in Natural Language Processing (NLP) technology, Yseop acts as a “Copilot” for medical writers, enhancing their efficiency and accuracy in generating pivotal reports essential for drug development and approval processes. By integrating cutting-edge language models, Yseop ensures that pharmaceutical firms effectively tackle the most demanding content tasks with ease, scalability, and utmost application security.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |